Ranitidine but not famotidine releases acetylcholine from the guinea pig myenteric plexus
- 1 April 1990
- journal article
- research article
- Published by Springer Nature in Inflammation Research
- Vol. 30 (1-2) , 191-194
- https://doi.org/10.1007/bf01969035
Abstract
The effects of the histamine H2-receptor antagonists ranitidine and famotidine on acetylcholine release have been studied in the guinea pig myenteric plexus longitudinal muscle preparation incubated with [3H]-choline. Ranitidine (3×10−5–3×10−4 M) dose-dependently increased the resting release of acetylcholine and that evoked by electrical stimulation. The effect was present only in strips perfused with 10−5 M physostigmine. The effect of ranitidinc was inhibited by tetrodotoxin and hexamethonium. Famotidine (10−5–3×10−4 M) was totally ineffective in modifying both the resting release and that evoked by field stimulation. Ranitidine did not antagonize the inhibitory effect of oxotremorine, which specifically activates negative feedback mechanisms via presynaptic muscarinic receptors.Keywords
This publication has 4 references indexed in Scilit:
- Pharmacology of the novel H2 antagonist famotidine: In vitro studiesInflammation Research, 1986
- INHIBITION OF CHOLINESTERASES BY RANITIDINEThe Lancet, 1983
- Cholinergic-like effects of the new histamine H2-receptor antagonist ranitidineInflammation Research, 1982
- EVIDENCE THAT MORPHINE AND OPIOID PEPTIDES DO NOT SHARE A COMMON PATHWAY WITH ADENOSINE IN INHIBITING ACETYLCHOLINE RELEASE FROM ISOLATED INTESTINEJournal of Autonomic Pharmacology, 1981